Lantigen B Bacterial Vaccine - For the Treatment of Catarrh, Chronic Bronchitis, and Bronchial Asthma

Lantigen B Bacterial Vaccine - For the Treatment of Catarrh, Chronic Bronchitis, and Bronchial Asthma

<< >>
Usage conditions apply
Downloads
Description
The indications or uses for this product as provided by the manufacturer are:
For the treatment of catarrh, chronic bronchitis, bronchial asthma
Location
Currently not on view
Object Name
biological
vaccine, respiratory infections, bacterial
Object Type
OTC Preparation
date made
1944-12-29
expiration date
1945-06-29
maker
Edinburgh Laboratories
place made
Australia: New South Wales, City of Sydney
Physical Description
pneumococci, 1000 million detoxified antigens per cc. (drug ingredient)
M. catarrhalis, 1000 million detoxified antigens per cc. (drug ingredient)
streptococci, 1000 million detoxified antigens per cc. (drug ingredient)
staphylococci, 500 million detoxified antigens per cc. (drug ingredient)
Bact.. friedlaenderi, 500 million detoxified antigens per cc. (drug ingredient)
H. influenzae, 500 million detoxified antigens per cc. (drug ingredient)
Measurements
overall: 2 in x 3 1/2 in; x 5.08 cm x 8.89 cm
overall, box: 3 3/8 in x 2 1/8 in x 1 1/4 in; 8.5725 cm x 5.3975 cm x 3.175 cm
ID Number
2008.0018.142
accession number
2008.0018
catalog number
2008.0018.142
Credit Line
Gift of Richard W. Pollay
See more items in
Medicine and Science: Medicine
The Antibody Initiative
Health & Medicine
Antibody Initiative: Influenza
Data Source
National Museum of American History
Nominate this object for photography.   

Our collection database is a work in progress. We may update this record based on further research and review. Learn more about our approach to sharing our collection online.

If you would like to know how you can use content on this page, see the Smithsonian's Terms of Use. If you need to request an image for publication or other use, please visit Rights and Reproductions.

Comments

Add a comment about this object